4//SEC Filing
Mergelmeyer Gene 4
Accession 0001209191-21-035735
CIK 0001267238other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:02 PM ET
Size
8.3 KB
Accession
0001209191-21-035735
Insider Transaction Report
Form 4
Mergelmeyer Gene
Executive Vice PresidentOther
Transactions
- Sale
Common Stock
2021-05-24$159.38/sh−40,647$6,478,425→ 66,796 total(indirect: By Trust)
Holdings
- 16,194
Common Stock
Footnotes (3)
- [F1]The price range in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.01 through $159.78, inclusive. The reporting person undertakes to provide Assurant, Inc., any security holder of Assurant, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth to this footnote to this Form 4.
- [F2]Includes 12,295 shares previously reported as directly owned but contributed to the Family Trust upon March 16, 2021 vesting.
- [F3]Includes restricted stock units.
Issuer
ASSURANT, INC.
CIK 0001267238
Entity typeother
Related Parties
1- filerCIK 0001407462
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 5:02 PM ET
- Size
- 8.3 KB